IBDEI0SO ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12904,1,3,0)
;;=3^Retinal Telangiectasis,OU
;;^UTILITY(U,$J,358.3,12904,1,4,0)
;;=4^H35.073
;;^UTILITY(U,$J,358.3,12904,2)
;;=^5005608
;;^UTILITY(U,$J,358.3,12905,0)
;;=H35.071^^51^623^34
;;^UTILITY(U,$J,358.3,12905,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12905,1,3,0)
;;=3^Retinal Telangiectasis,OD
;;^UTILITY(U,$J,358.3,12905,1,4,0)
;;=4^H35.071
;;^UTILITY(U,$J,358.3,12905,2)
;;=^5005606
;;^UTILITY(U,$J,358.3,12906,0)
;;=H35.072^^51^623^35
;;^UTILITY(U,$J,358.3,12906,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12906,1,3,0)
;;=3^Retinal Telangiectasis,OS
;;^UTILITY(U,$J,358.3,12906,1,4,0)
;;=4^H35.072
;;^UTILITY(U,$J,358.3,12906,2)
;;=^5005607
;;^UTILITY(U,$J,358.3,12907,0)
;;=H34.03^^51^623^23
;;^UTILITY(U,$J,358.3,12907,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12907,1,3,0)
;;=3^Transient Retinal Artery Occlusion,OU
;;^UTILITY(U,$J,358.3,12907,1,4,0)
;;=4^H34.03
;;^UTILITY(U,$J,358.3,12907,2)
;;=^5005555
;;^UTILITY(U,$J,358.3,12908,0)
;;=H34.01^^51^623^21
;;^UTILITY(U,$J,358.3,12908,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12908,1,3,0)
;;=3^Transient Retinal Artery Occlusion,OD
;;^UTILITY(U,$J,358.3,12908,1,4,0)
;;=4^H34.01
;;^UTILITY(U,$J,358.3,12908,2)
;;=^5005553
;;^UTILITY(U,$J,358.3,12909,0)
;;=H34.02^^51^623^22
;;^UTILITY(U,$J,358.3,12909,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12909,1,3,0)
;;=3^Transient Retinal Artery Occlusion,OS
;;^UTILITY(U,$J,358.3,12909,1,4,0)
;;=4^H34.02
;;^UTILITY(U,$J,358.3,12909,2)
;;=^5005554
;;^UTILITY(U,$J,358.3,12910,0)
;;=H35.00^^51^623^47
;;^UTILITY(U,$J,358.3,12910,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12910,1,3,0)
;;=3^Background Retinopathy,Unspec
;;^UTILITY(U,$J,358.3,12910,1,4,0)
;;=4^H35.00
;;^UTILITY(U,$J,358.3,12910,2)
;;=^5005581
;;^UTILITY(U,$J,358.3,12911,0)
;;=H34.823^^51^623^50
;;^UTILITY(U,$J,358.3,12911,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12911,1,3,0)
;;=3^Venous Engorgement,OU
;;^UTILITY(U,$J,358.3,12911,1,4,0)
;;=4^H34.823
;;^UTILITY(U,$J,358.3,12911,2)
;;=^5005574
;;^UTILITY(U,$J,358.3,12912,0)
;;=H34.821^^51^623^48
;;^UTILITY(U,$J,358.3,12912,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12912,1,3,0)
;;=3^Venous Engorgement,OD
;;^UTILITY(U,$J,358.3,12912,1,4,0)
;;=4^H34.821
;;^UTILITY(U,$J,358.3,12912,2)
;;=^5005572
;;^UTILITY(U,$J,358.3,12913,0)
;;=H34.822^^51^623^49
;;^UTILITY(U,$J,358.3,12913,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12913,1,3,0)
;;=3^Venous Engorgement,OS
;;^UTILITY(U,$J,358.3,12913,1,4,0)
;;=4^H34.822
;;^UTILITY(U,$J,358.3,12913,2)
;;=^5005573
;;^UTILITY(U,$J,358.3,12914,0)
;;=H34.9^^51^623^24
;;^UTILITY(U,$J,358.3,12914,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12914,1,3,0)
;;=3^Retinal Vascular Occlusion,Unspec
;;^UTILITY(U,$J,358.3,12914,1,4,0)
;;=4^H34.9
;;^UTILITY(U,$J,358.3,12914,2)
;;=^5005580
;;^UTILITY(U,$J,358.3,12915,0)
;;=H52.201^^51^624^2
;;^UTILITY(U,$J,358.3,12915,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12915,1,3,0)
;;=3^Astigmatism,Unspec,Rt Eye
;;^UTILITY(U,$J,358.3,12915,1,4,0)
;;=4^H52.201
;;^UTILITY(U,$J,358.3,12915,2)
;;=^5006267
;;^UTILITY(U,$J,358.3,12916,0)
;;=H52.202^^51^624^3
;;^UTILITY(U,$J,358.3,12916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12916,1,3,0)
;;=3^Astigmatism,Unspec,Lt Eye
;;^UTILITY(U,$J,358.3,12916,1,4,0)
;;=4^H52.202
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0SO 3760 printed Dec 13, 2024@01:55 Page 2
IBDEI0SO ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12904,1,3,0)
+2 ;;=3^Retinal Telangiectasis,OU
+3 ;;^UTILITY(U,$J,358.3,12904,1,4,0)
+4 ;;=4^H35.073
+5 ;;^UTILITY(U,$J,358.3,12904,2)
+6 ;;=^5005608
+7 ;;^UTILITY(U,$J,358.3,12905,0)
+8 ;;=H35.071^^51^623^34
+9 ;;^UTILITY(U,$J,358.3,12905,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,12905,1,3,0)
+12 ;;=3^Retinal Telangiectasis,OD
+13 ;;^UTILITY(U,$J,358.3,12905,1,4,0)
+14 ;;=4^H35.071
+15 ;;^UTILITY(U,$J,358.3,12905,2)
+16 ;;=^5005606
+17 ;;^UTILITY(U,$J,358.3,12906,0)
+18 ;;=H35.072^^51^623^35
+19 ;;^UTILITY(U,$J,358.3,12906,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,12906,1,3,0)
+22 ;;=3^Retinal Telangiectasis,OS
+23 ;;^UTILITY(U,$J,358.3,12906,1,4,0)
+24 ;;=4^H35.072
+25 ;;^UTILITY(U,$J,358.3,12906,2)
+26 ;;=^5005607
+27 ;;^UTILITY(U,$J,358.3,12907,0)
+28 ;;=H34.03^^51^623^23
+29 ;;^UTILITY(U,$J,358.3,12907,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,12907,1,3,0)
+32 ;;=3^Transient Retinal Artery Occlusion,OU
+33 ;;^UTILITY(U,$J,358.3,12907,1,4,0)
+34 ;;=4^H34.03
+35 ;;^UTILITY(U,$J,358.3,12907,2)
+36 ;;=^5005555
+37 ;;^UTILITY(U,$J,358.3,12908,0)
+38 ;;=H34.01^^51^623^21
+39 ;;^UTILITY(U,$J,358.3,12908,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,12908,1,3,0)
+42 ;;=3^Transient Retinal Artery Occlusion,OD
+43 ;;^UTILITY(U,$J,358.3,12908,1,4,0)
+44 ;;=4^H34.01
+45 ;;^UTILITY(U,$J,358.3,12908,2)
+46 ;;=^5005553
+47 ;;^UTILITY(U,$J,358.3,12909,0)
+48 ;;=H34.02^^51^623^22
+49 ;;^UTILITY(U,$J,358.3,12909,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,12909,1,3,0)
+52 ;;=3^Transient Retinal Artery Occlusion,OS
+53 ;;^UTILITY(U,$J,358.3,12909,1,4,0)
+54 ;;=4^H34.02
+55 ;;^UTILITY(U,$J,358.3,12909,2)
+56 ;;=^5005554
+57 ;;^UTILITY(U,$J,358.3,12910,0)
+58 ;;=H35.00^^51^623^47
+59 ;;^UTILITY(U,$J,358.3,12910,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,12910,1,3,0)
+62 ;;=3^Background Retinopathy,Unspec
+63 ;;^UTILITY(U,$J,358.3,12910,1,4,0)
+64 ;;=4^H35.00
+65 ;;^UTILITY(U,$J,358.3,12910,2)
+66 ;;=^5005581
+67 ;;^UTILITY(U,$J,358.3,12911,0)
+68 ;;=H34.823^^51^623^50
+69 ;;^UTILITY(U,$J,358.3,12911,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,12911,1,3,0)
+72 ;;=3^Venous Engorgement,OU
+73 ;;^UTILITY(U,$J,358.3,12911,1,4,0)
+74 ;;=4^H34.823
+75 ;;^UTILITY(U,$J,358.3,12911,2)
+76 ;;=^5005574
+77 ;;^UTILITY(U,$J,358.3,12912,0)
+78 ;;=H34.821^^51^623^48
+79 ;;^UTILITY(U,$J,358.3,12912,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,12912,1,3,0)
+82 ;;=3^Venous Engorgement,OD
+83 ;;^UTILITY(U,$J,358.3,12912,1,4,0)
+84 ;;=4^H34.821
+85 ;;^UTILITY(U,$J,358.3,12912,2)
+86 ;;=^5005572
+87 ;;^UTILITY(U,$J,358.3,12913,0)
+88 ;;=H34.822^^51^623^49
+89 ;;^UTILITY(U,$J,358.3,12913,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,12913,1,3,0)
+92 ;;=3^Venous Engorgement,OS
+93 ;;^UTILITY(U,$J,358.3,12913,1,4,0)
+94 ;;=4^H34.822
+95 ;;^UTILITY(U,$J,358.3,12913,2)
+96 ;;=^5005573
+97 ;;^UTILITY(U,$J,358.3,12914,0)
+98 ;;=H34.9^^51^623^24
+99 ;;^UTILITY(U,$J,358.3,12914,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,12914,1,3,0)
+102 ;;=3^Retinal Vascular Occlusion,Unspec
+103 ;;^UTILITY(U,$J,358.3,12914,1,4,0)
+104 ;;=4^H34.9
+105 ;;^UTILITY(U,$J,358.3,12914,2)
+106 ;;=^5005580
+107 ;;^UTILITY(U,$J,358.3,12915,0)
+108 ;;=H52.201^^51^624^2
+109 ;;^UTILITY(U,$J,358.3,12915,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,12915,1,3,0)
+112 ;;=3^Astigmatism,Unspec,Rt Eye
+113 ;;^UTILITY(U,$J,358.3,12915,1,4,0)
+114 ;;=4^H52.201
+115 ;;^UTILITY(U,$J,358.3,12915,2)
+116 ;;=^5006267
+117 ;;^UTILITY(U,$J,358.3,12916,0)
+118 ;;=H52.202^^51^624^3
+119 ;;^UTILITY(U,$J,358.3,12916,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,12916,1,3,0)
+122 ;;=3^Astigmatism,Unspec,Lt Eye
+123 ;;^UTILITY(U,$J,358.3,12916,1,4,0)
+124 ;;=4^H52.202
